Skip to content
thestock.space

As of 6 Nov 2026, CARE Ratings trades at 24.5× trailing earnings, below the industry P/E of 38.2×, and the shares are 15% below their 52-week high. It earns ROCE of 24% and ROE of 21%, and sales and net profit grew 19% and 27% a year over 3 years. It has almost no debt, and its dividend yield is 1.3%. It is a small-cap company with a market cap of ₹4,716 Cr, ranked 6th of 7 Financial Data & Stock Exchanges companies by market cap; the shares fell 1.1% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹1,575.50
Day high
₹1,579.90
Day low
₹1,534.50
Prev. close
₹1,588.10
Volume
64.6K

Health check

3 good · 3 fair
  • ReturnsIn line

    −1.1% over a year, better than 3 of 6 peers.

  • Price tagCheaper

    P/E 24.5 vs industry 38.2.

  • GrowthSteady

    Sales +19.2%, profit +27.0% a year over 3 years.

  • ProfitabilityAverage

    ROCE 24.1% vs peer median 30.6%.

  • Balance sheetSolid

    Practically debt-free, Piotroski 6 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 6 industry peers. Computed from reported figures. Educational, not a recommendation.

Financial Data & Stock Exchanges

6 listed peers. Screen the industry

Small cap

₹4,716 Cr, #6 of 7 in its industry by size.

Defensive

Beta 0.31 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹519 Cr · profit ₹193 Cr
Market cap
₹4,716 Cr
Small cap
P/E
24.5
Industry 38.2
Price to book
4.70
Peers 10.43
Dividend yield
1.28%
ROE
20.7%
Peers 27.0%
ROCE
24.1%
Peers 30.6%
Debt to equity
0.02
Debt ₹24 Cr
EPS (TTM)
₹63.94
Face value ₹10
OPM (TTM)
42.5%
Net margin 37.2%
Sales growth
+20.4%
Latest quarter vs a year ago
Profit growth
+26.8%
Latest quarter vs a year ago
Price to sales
9.09
EV/EBITDA 18.4

Strengths and risks

Strengths

  • Return on equity of 20.7%.
  • Return on capital employed of 24.1%.
  • Practically debt-free.
  • Quarterly profit up 26.8% on a year ago.
  • Quarterly sales up 20.4% on a year ago.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About CARE Ratings

CARE Ratings Limited, a credit rating agency, provides various rating and related services in India and internationally. It offers rating services for bank loan, debt instrument, bonds, long and short term instruments, InvITs, resolution plan, and non-convertible debentures; CDs for banks, bonds, mutual funds, and hybrid instruments; bank debt and capital market instruments, such as commercial papers, corporate bonds and debentures, and structured credit;…

Headquarters
Mumbai
Employees
608
Sector
Financial Services
ISIN
INE752H01013

Price range

52 weeks

₹1,392.70₹1,838.00

Today

₹1,534.50₹1,579.90
Avg volume (3M)
54K
1-year return
minus 1.1%
From 52-week high
minus 14.9%

Peers · Financial Data & Stock Exchanges

Company
NSENational Stock Exchange of Ind1,908.35plus 0.74%4,72,31743.111.0330.2%26.7%78.3%––0.00%plus 5.0%
BSEBSE3,800.00plus 0.26%1,54,32950.816.9540.9%38.7%65.7%76.5%124.5%0.26%plus 51.8%
MCXMulti Commodity Exchange of India3,528.00plus 4.81%89,79360.918.0539.0%44.4%74.2%67.8%107.5%0.23%plus 80.5%
CRISILCRISIL4,395.40minus 0.75%32,14435.99.8331.0%27.4%30.5%9.6%10.7%1.55%minus 7.3%
NSDLNational Securities Depository764.15minus 1.25%15,28338.26.0921.2%17.1%25.4%14.4%17.4%0.52%minus 29.9%
CARERATINGCARE Ratings1,564.20minus 1.50%4,71624.54.7024.1%20.7%42.5%19.2%27.0%1.28%minus 1.1%
ICRAICRA4,431.40minus 1.57%4,26721.43.5820.5%17.5%35.4%14.3%10.3%1.58%minus 30.4%
Median of 6 peers–−0.24%60,96840.610.4330.6%27.0%50.5%14.4%17.4%0.39%−1.2%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
136112131112164
6871.869.97779.5
68.440.360.834.684.6
50.2%36.0%46.5%31.0%51.6%
12.61315.714.815.4
0.60.60.60.60.6
3.53.73.83.93.9
76.949724595.6
25.6%25.4%25.8%26.6%24.3%
56.735.952.832.371.8
18.8111.9117.5110.7023.82

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+19.2%
Profit CAGR 3Y
+27.0%
EPS CAGR 3Y
+26.3%
ROE
20.7%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
279332402473
–+18.9%+21.3%+17.6%
174218246275
105113156198
37.7%34.1%38.8%41.9%
37.34446.351.2
11.72.12.5
10.510.511.714.4
−5.21.63.63
126147192235
32.0%30.1%27.2%26.2%
83.5101137171
–+20.3%+36.5%+24.7%
28.1733.6745.6956.83

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
29.729.929.930
643687776902
17.519.623.826.2
79.9105128146
7708429581,105
97.498.1103105
–0.31.30.2
55.650.4139291
565626641619
51.96773.789.5
7708429581,105

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
82.290.9123148
12.9−39.1−58.4−94.5
−63.3−63−54−59.3
31.8−11.110.5−6.2
−11.5−9.2−14.7−8.3
70.781.7108139
−59.8−66.9−54.9−58.4

Shareholding pattern

Source: NSE filings
0.0%
promoters
  • Public100.00%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 20260.00%100.00%0.00
30 Jun 20260.00%100.00%0.00
31 Mar 20260.00%100.00%0.00
31 Dec 20250.00%100.00%0.00
30 Sep 20250.00%100.00%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you